On Monday, August 3rd, the Food and Drug Administration (FDA) approved the first 3D printed pill, signaling a new opportunity for drug makers and 3D printing technology.
Spritam, a medication for epilepsy, is manufactured by Ohio-based pharmaceutical company, Aprecia Pharmaceuticals. This particular drug has already been on the market, but the new, 3D printed version, is designed to dissolve more rapidly than any other seizure medication. This new design also allows for a high drug load to be delivered in a single dose, limiting the number of pills necessary. The 3D printed design may be particularly helpful for children or other patients who have difficulty swallowing large pills. By layering medication, 3D printing allows the creation of a more porous pill that can dissolve more quickly into liquid. The pill should be available commercially early in 2016.